HUS Group is surveying solutions and service providers on the market to organize external clinical audits of radiation use.
The procurement concerns the operations of HUS Group involving medical exposure class 1 of radiation use.
The offered audit must cover the radiation use activities in specialized medical care and primary health care within the HUS care area, according to the related exposure class of the audit package.
Clinical audit refers to an external evaluation meeting the requirements of the following regulations:
- Radiation Act 859/2018
- Government Decree on Ionizing Radiation 1034/2018
- Ministry of Social Affairs and Health Decree on Ionizing Radiation 1044/2018
- Radiation and Nuclear Safety Authority regulations (S-series)
- Recommendations 1–19 by the clinical expert group under the Ministry of Social Affairs and Health.
Clinical audits must be completed by the end of 2028. The audit must cover the scope and content to meet the above regulatory requirements. Where the audit requires a visit to the operational unit, audits must be carried out on weekdays during normal office hours. Furthermore, the audit schedule should be arranged to minimize disruption to normal clinical activities.
The audit package comprises the following subcomponents:
1. Angiography operations at HUS Diagnostic Center
2. Isotope operations at HUS Diagnostic Center
3. Angiography operations at HUS Heart and Lung Center
4. Angiography operations in HUS surgical departments
5. Radiation therapy and isotope operations at HUS Cancer Center
Audits shall be conducted in accordance with the Radiation Act and Decree, Ministry of Social Affairs and Health Decree 1044/2018, and recommendations 1–19 issued by the Ministry’s clinical audit expert group. A written audit report meeting the regulatory requirements must be produced. The audit company must report in writing every three months on the progress of audits compared to the audit plan to the project group coordinating radiation use audits.
Locations and geographical areas of subcomponent operations:
Radiology functions:
Angiography operations at Diagnostic Center:
- Meilahti Tower Hospital (5 angiography rooms)
- Siltasairaala (2 rooms)
- Kymenlaakso Central Hospital (1 angiography room)
- South Karelia Central Hospital (1 angiography room)
HUS surgical operations:
- Meilahti Tower Hospital (1 hybrid room)
- Siltasairaala (3 hybrid rooms + Raptor room)
- New Children’s Hospital (1 hybrid room + 1 cardiac catheterization laboratory angiography room)
HUS heart station operations:
- Meilahti Tower Hospital Heart Station (6 angiography rooms)
- Jorvi Hospital Heart Station (3 angiography rooms)
- Peijas Hospital Heart Station (1 angiography room)
- Hyvinkää Hospital Heart Station (1 angiography room)
HUS Cancer Center:
• Safety Permit 2517 (radiation therapy)
- Cancer Center, Haartmaninkatu 4 / Paciuksenkatu 3: 13 linear accelerators, 2 afterloading devices, 4 imaging devices for radiation therapy planning, 1 BNCT treatment device
- Intraocular radiation therapy (Tammisaari Hospital and Cancer Center)
• Safety Permit 145 (radiopharmaceutical operations)
- Cancer Center, Haartmaninkatu 4 / Paciuksenkatu 3: 2 SPECT-CT devices, radiopharmaceutical manufacturing, outpatient radiopharmaceutical treatments and treatments in ward S4A (Siltasairaala)
The estimated contract start date is 5 April 2027. The purpose of this request for information is to gather data about implementation models and operational environment. The information will be utilized in the preparation of the request for tenders. This is not a procurement notice and does not bind the contracting authority.
Information requested from service providers
Overall service
The purchaser has planned the division of the audit package into subcomponents 1–5 as described above.
- Do you consider the presented division into subcomponents functional, or would you suggest another model, for example, division by isotope/radiology/radiation therapy?
Submission of responses
We invite interested suppliers to describe solutions offered, considering the background and goals of the procurement outlined above. Please submit responses to this request for information by 18 August 2026 to the address kilpailutus.palvelut@hus.fi. Please use the email subject line "Request for Information External Clinical Audits of Radiation Use [Company Name] [dd.mm.yyyy]".
This request for information is not a procurement notice and does not constitute a commitment to purchase. The information collected will be used in preparing the procurement.
Responses provided to this request for information may be used in planning the procurement. Suppliers who respond may possibly be given a chance to comment on preliminary tender documents.
The contracting authority will not initiate a tendering procedure by publishing this request for information. A possible procurement notice and request for tenders will be published later. This request for information does not oblige the contracting authority to carry out a procurement. Responding to this request for information is not a prerequisite for participation in any later tendering process.
LOT-0000
2026-054092-LOT-0001
Request for Information: External Clinical Audits of Radiation Use.
HUS Group is surveying solutions and service providers on the market to organize external clinical audits of radiation use.
The procurement concerns the operations of HUS Group involving medical exposure class 1 of radiation use.
The offered audit must cover the radiation use activities in specialized medical care and primary health care within the HUS care area, according to the related exposure class of the audit package.
Clinical audit refers to an external evaluation meeting the requirements of the following regulations:
- Radiation Act 859/2018
- Government Decree on Ionizing Radiation 1034/2018
- Ministry of Social Affairs and Health Decree on Ionizing Radiation 1044/2018
- Radiation and Nuclear Safety Authority regulations (S-series)
- Recommendations 1–19 by the clinical expert group under the Ministry of Social Affairs and Health.
Clinical audits must be completed by the end of 2028. The audit must cover the scope and content to meet the above regulatory requirements. Where the audit requires a visit to the operational unit, audits must be carried out on weekdays during normal office hours. Furthermore, the audit schedule should be arranged to minimize disruption to normal clinical activities.
The audit package comprises the following subcomponents:
1. Angiography operations at HUS Diagnostic Center
2. Isotope operations at HUS Diagnostic Center
3. Angiography operations at HUS Heart and Lung Center
4. Angiography operations in HUS surgical departments
5. Radiation therapy and isotope operations at HUS Cancer Center
Audits shall be conducted in accordance with the Radiation Act and Decree, Ministry of Social Affairs and Health Decree 1044/2018, and recommendations 1–19 issued by the Ministry’s clinical audit expert group. A written audit report meeting the regulatory requirements must be produced. The audit company must report in writing every three months on the progress of audits compared to the audit plan to the project group coordinating radiation use audits.
Locations and geographical areas of subcomponent operations:
Radiology functions:
Angiography operations at Diagnostic Center:
- Meilahti Tower Hospital (5 angiography rooms)
- Siltasairaala (2 rooms)
- Kymenlaakso Central Hospital (1 angiography room)
- South Karelia Central Hospital (1 angiography room)
HUS surgical operations:
- Meilahti Tower Hospital (1 hybrid room)
- Siltasairaala (3 hybrid rooms + Raptor room)
- New Children’s Hospital (1 hybrid room + 1 cardiac catheterization laboratory angiography room)
HUS heart station operations:
- Meilahti Tower Hospital Heart Station (6 angiography rooms)
- Jorvi Hospital Heart Station (3 angiography rooms)
- Peijas Hospital Heart Station (1 angiography room)
- Hyvinkää Hospital Heart Station (1 angiography room)
HUS Cancer Center:
• Safety Permit 2517 (radiation therapy)
- Cancer Center, Haartmaninkatu 4 / Paciuksenkatu 3: 13 linear accelerators, 2 afterloading devices, 4 imaging devices for radiation therapy planning, 1 BNCT treatment device
- Intraocular radiation therapy (Tammisaari Hospital and Cancer Center)
• Safety Permit 145 (radiopharmaceutical operations)
- Cancer Center, Haartmaninkatu 4 / Paciuksenkatu 3: 2 SPECT-CT devices, radiopharmaceutical manufacturing, outpatient radiopharmaceutical treatments and treatments in ward S4A (Siltasairaala)
The estimated contract start date is 5 April 2027. The purpose of this request for information is to gather data about implementation models and operational environment. The information will be utilized in the preparation of the request for tenders. This is not a procurement notice and does not bind the contracting authority.
Information requested from service providers
Overall service
The purchaser has planned the division of the audit package into subcomponents 1–5 as described above.
- Do you consider the presented division into subcomponents functional, or would you suggest another model, for example, division by isotope/radiology/radiation therapy?
Submission of responses
We invite interested suppliers to describe solutions offered, considering the background and goals of the procurement outlined above. Please submit responses to this request for information by 18 August 2026 to the address kilpailutus.palvelut@hus.fi. Please use the email subject line "Request for Information External Clinical Audits of Radiation Use [Company Name] [dd.mm.yyyy]".
This request for information is not a procurement notice and does not constitute a commitment to purchase. The information collected will be used in preparing the procurement.
Responses provided to this request for information may be used in planning the procurement. Suppliers who respond may possibly be given a chance to comment on preliminary tender documents.
The contracting authority will not initiate a tendering procedure by publishing this request for information. A possible procurement notice and request for tenders will be published later. This request for information does not oblige the contracting authority to carry out a procurement. Responding to this request for information is not a prerequisite for participation in any later tendering process.